Don't miss an issue! Renew/subscribe for FREE today.

Planmeca Strategic Expansion of CBCT Imaging with New Product Release

Posted on Friday, May 17, 2024

Planmeca announces the expansion of the superior imaging line to include the Planmeca Viso® G3 for the North American market—a multifunctional CBCT device to meet all 2D to 3D extraoral imaging needs. The Planmeca Viso® G3 completes Planmeca’s next-generation CBCT units alongside Planmeca Viso® G7 and Planmeca Viso® G5—all powered by all-in-one Planmeca Romexis® dental software.

“We are thrilled to offer this addition to our highly regarded Viso product line,” stated Glen Kendrick, Planmeca USA President. With all the benefits of Planmeca Viso technology, the Viso G3 allows clinics desiring a 3D with fantastic usability and outstanding image quality to be introduced to the superiority of Planmeca CBCT imaging.”

Planmeca Viso® G3 brings industry-leading usability and visibility for diverse clinics and clinical needs, from endodontics to implantology. With a Field of View (FOV) ranging from 3 x 3 to 20 x 10 cm, the Planmeca Viso® G3 offers high-quality 3D images of the full dentition and the capacity to capture detailed panoramic images and bitewing images for highly detailed diagnosis of interproximal caries.

Planmeca Viso® G3 has advanced features to ensure patient safety. These include the Planmeca Ultra Low Dose™ protocol, which has been scientifically proven in nine studies to reduce the effective patient dose without a statistical reduction in image quality. Additionally, the proprietary Planmeca CALM® algorithm for motion artifact correction can be applied both before and after acquisition to reduce the need for retakes, limiting radiation exposure. The Planmeca Viso® G3 includes freely adjustable 3D volume size and anatomical target selection. The user-friendly patient positioning programs, which include a live video view and virtual FOV adjustments, prioritize a patient comfort workflow. The Planmeca Viso® G3 feature set provides a smooth and efficient imaging workflow without compromising safety or patient comfort.

Planmeca’s innovative product design assures that the Planmeca Viso® G3 can be upgraded to Planmeca Viso® G5 for a larger maximum 3D volume, securing a sustainable solution to grow with an expanding practice. Additionally, expanded treatment capability is available with the addition of the Planmeca ProCeph™ one-shot cephalostat.

About Planmeca USA:

Planmeca USA is a subsidiary of Planmeca, the largest privately held company in the dental equipment market and one of the industry’s leading manufacturers of dental X-rays, CAD/CAM, and core equipment. With a North American office located in Charlotte, North Carolina, and international headquarters in Helsinki, Finland, Planmeca is well established in high-tech dental markets and currently serves 120 countries worldwide. For more information, visit


Recent Headlines

© 2024 Conexiant | Privacy Policy